TrialAdvances in therapy2015

Pharmacokinetics, Pharmacodynamics, and Safety of Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Single-blind, Placebo-controlled Trial.

Takashi Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.